Pfizer Inc (PFE)

48.20
+2.89(+6.39%)
  • Volume:
    1,643
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    44.60 - 48.55
  • Type:Equity
  • Market:Germany
  • ISIN:US7170811035

PFE Overview

Prev. Close
45.31
Day's Range
44.6-48.55
Revenue
-
Open
44.6
52 wk Range
27.62-48.55
EPS
-
Volume
1,643
Market Cap
267.75B
Dividend (Yield)
1.29
(3.34%)
Average Vol. (3m)
1,085
P/E Ratio
-
Beta
-
1-Year Change
56.49%
Shares Outstanding
5,612,866,598
Next Earnings Date
Feb 01, 2022
What is your sentiment on Pfizer Inc?
or
Market is currently closed. Voting is open during market hours.

Pfizer Inc Company Profile

Employees
78500

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; Arvinas, Inc.; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
  • I meant mark my word
    0
    • I predicted this yesterday and now the price is rising..... it's will rise above $150 per share before the end of this year.... mark my work
      7
      • Are you serious?, its unbelievable !!!
        1
    • easy short
      3
      • $200 per share target
        5
        • Ply
          0
          • Easy double from here
            6
            • https://money.cnn.com/quote/forecast/forecast.html?symb=PFEHold for nowBest case 61
              1
              • buy and hold
                2
                • 80 soon
                  0
                  • Should have been 150
                    0
                  • dont scare Ray and Ford...let them have a peaceful thanksgiving
                    1
                  • give me help plz im indian u give me advice what's stock news today
                    0
                • insider on stocks that will rise in price by 35% bery, pba, dhr, bll, tdg!
                  0
                  • that was odd stretch on the weekly chart my bet is up we go
                    3
                    • pfizer may dip when it hits 55 to 60, and come back to 50, so you guys can hedge a little bit when you recognise the trend, right Mr Ford
                      3
                      • This is the dip!!!
                        0
                        • Ray Ray Ray
                          3
                          • 🍑🍌🍌
                            0
                        • Now.. go to the moon
                          1
                          • Its Lunch time bois, lets sell the top and buy the dip and hold for the run🥂
                            0
                            • How dip that u think?
                              0
                            • Happy Holidays. Enjoy 🥂
                              0
                            • This is the dip!!!
                              0
                          • Jesus, more lockdowns here in Europe, Europe is in chaos, the MRNA vaccine has failed, doesnt hold up at all, this is the perfect time for Novavax to sweep the floor and save us all!
                            2
                            • ray is silent?????
                              0
                              • 😂😂😂😂😂😂
                                0
                              • He's busy cooking up the next conspiracies!
                                0
                            • Up to 55-60-75...120
                              0
                              • You miss the train if you sell, look at prices of the others….
                                0
                                • But analysts predict 61. I would not be so sure
                                  2
                                  • Time to sell i think
                                    7
                                    • $60 within couple of days
                                      0
                                  • Well now, we all know it's only fun to brag,,,when we are right. 😉
                                    0
                                    • tomorrow pop or drop it's one or the other should be big
                                      0
                                      • Calms reigns without “Ford”. Prices go up without “Ford”. 🍑🍌
                                        0
                                        • Ford might prepare another better point to short such as 55... another short sell 1200 shares ... and 62 another 1200 shares... finally Ford will wim and sold the highest point...
                                          0
                                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.